OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 211 - 220 of 700 studies

Reproductive health and childbirth

Bicarbonate for AcidosiS in very pretErm babies: a randomised clinical trial: The BASE Trial (BASE)

Sodium bicarbonate is widely,but not universally,used to treat metabolic acidosis in very preterm babies but the evidence underpinning its use is poor. The BASE trial aims to answer the question,‘In very preterm babies with metabolic acidosis,does giving them sodium bicarbonate or not impact on their health and development in the short and long term?’ The primary objective of the BASE trial is to evaluate the effect of sodium bicarbonate on survival to discharge from neonatal care without major morbidity. In this randomised ...

GO TO STUDY Go

A Phase 1/2 Study of REGN4018 (A MUC16xCD3 Bispecific Antibody) Administered Alone or in Combination with Cemiplimab in Patients with Recurrent Ovarian Cancer

REGN4018 and cemiplimab are the study drugs under investigation for the treatment of ovarian cancer. They are both investigational drugs, meaning they have not received approval from health authorities for the treatment of ovarian cancer. The purpose of this study is to learn about the safety of REGN4018 and to find out what dose of REGN4018 can be given alone or with cemiplimab to patients with ovarian cancer, without causing too many side effects. The study will also look at ...

GO TO STUDY Go

Cardiovascular

Effect of fetal aortic valvuloplasty on outcomes. A prospective observational cohort study with a comparison cohort.

In one of the most severe congenital heart defects, hypoplastic left heart syndrome (HLHS), the left ventricle is underdeveloped and the prognosis is worse than in most other heart defects. The underdevelopment can occur gradually during fetal growth caused by a narrowing of the aortic valve. At some international centers, such fetuses are treated with a balloon dilation of the narrowed valve, but there is no scientifically sound evidence that this treatment is effective. The aim of this study is: 1/ ...

GO TO STUDY Go

Musculoskeletal

The Meniscal Transplant surgery or Optimised Rehabilitation full randomised trial (MeTeOR2)

The Meniscus is an important structure within the knee. One of its key roles is to cushion impact and protect the gliding surface of the joint from wear. Patients that have damaged their meniscus, and had a removal of the meniscus (a total meniscectomy), are more likely to develop persistent pain after this resulting in years of disability. At present, there are several treatment options ranging from knee therapy (physiotherapy) to a replacement meniscus also known as a ‘meniscal transplant’. Mensical transplant is thought ...

GO TO STUDY Go

Metabolic and Endocrine

A study to determine a capillary alternative to the gold standard oral glucose tolerance test

Type 1 diabetes (T1D) is a chronic condition of childhood, affecting 1 in 490 children under the age of 15 years. It is caused by the immune system damaging the pancreas, the organ which makes insulin, and impacts every aspect of a person’s life. T1D has recognised stages before symptoms develop, providing an opportunity for early diagnosis, education and treatment which may delay the onset of symptoms. Early diagnosis often relies on a test called the oral glucose tolerance test ...

GO TO STUDY Go

Cancer and neoplasms

Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects with Non-Small Cell Lung Cancer (MYTX-011-01)

MYTX-011 is a cMET-targeted val-cit-monomethyl auristatin E (vcMMAE) antibody-drug conjugate (ADC) with a fully humanized immunoglobulin (Ig)G1. The drug-to-antibody ratio (DAR) for MYTX-011 is 2:1. MYTX-011 binds to cMET with high affinity and specificity. MYTX-011 has been engineered to have pH dependent binding, which results in higher internalization and payload delivery to cMET+ tumor cells. This is manifested as increased internalization in cMET+ tumor cells in vitro compared to a non-engineered parent ADC and greater in vivo efficacy in murine ...

GO TO STUDY Go

Cancer and neoplasms

A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT)

Glioblastoma multiforme is a type of brain tumour. When it is first diagnosed,patients are usually treated with surgery and then a combination of radiotherapy and chemotherapy with temozolomide. Unfortunately,although this often slows or stops the disease from growing for a period of time,in most cases,usually a few months after the end of the original treatment,the tumour starts to grow again. This can be detected by an MRI scan. When this happens patients may experience new symptoms or a repeat of ...

GO TO STUDY Go

Oral and Gastrointestinal Reproductive health and childbirth

The neoGASTRIC trial: Avoiding routine gastric residual volume measurement in neonatal critical care, a multi-centre randomised controlled trial (neoGASTRIC)

About one in seven babies born in the UK each year need specialist neonatal care in a hospital because they are born too early,are born very small or have a medical condition.Ensuring these babies have enough nutrition is a key part of their care. Premature babies are fed milk every few hours through a soft plastic tube into their stomach, called a gastric tube. As their stomachs and digestive systems are not yet ready for lots of milk, the amount given ...

GO TO STUDY Go

Neurological

A C9orf72 HRE+ National Register and Characterisation Study (ACORN)

The purpose of this study is to investigate possible causes of nerve damage in patients carrying a genetic abnormality in the gene known as C9orf72, which is the cause of the diseases Amyotrophic Lateral Sclerosis (ALS; also known as motor neuron disease or MND) and Frontotemporal Dementia (FTD) in some people with these conditions. To carry out the study, we will take samples from and perform scans of the nervous system of carriers of the C9orf72 gene abnormality who have ...

GO TO STUDY Go

Cancer and neoplasms

Zanubrutinib plus rituximab (Zanu-R) as fixed duration, early intervention versus observation for patients with indolent mantle cell lymphoma: a randomised phase II clinical trial (ZEBRA)

Mantle cell lymphoma (MC) is an uncommon type of non-Hodgkins lymphoma. Most patients with MCL need to stat treatment soon after diagnosis,usually with a combination of chemotherapy and a 'targeted' treatment called rituximab. 25-30% of patients have 'indolent' (non-aggressive) MCL where the standard approach is an initial period of 'watchful waiting' followed by treatment with rituximab and chemotherapy when the lymphoma worsens (progresses). In this trial we will investigate whether there is a benefit of giving earlier treatment with ...

GO TO STUDY Go